Overview

VENTURI (VENTilation Using Respiratory Imaging)

Status:
NOT_YET_RECRUITING
Trial end date:
2030-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to enroll participants with uncontrolled asthma to evaluate the large and small airways and drug delivery utilizing two study drugs: * Beclometasone dipropionate/Formoterol fumarate dihydrate/Glycopyrronium bromide (BDP/FF/G) or Trimbow * Fluticasone furoate/Umeclidinium/Vilanterol (FluF/UMEC/VI ) or Trelegy Ellipta
Phase:
PHASE2
Details
Lead Sponsor:
University of Alabama at Birmingham
Treatments:
Beclomethasone
fluticasone furoate
GSK573719
vilanterol